Cara Therapeutics Inc (NASDAQ:CARA)

BATS BZX Real-Time Price
As of 11:39am ET
 +0.07 / +0.37%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Cara Therapeutics Inc have a median target of 36.00, with a high estimate of 47.00 and a low estimate of 21.00. The median estimate represents a +89.57% increase from the last price of 18.99.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Cara Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -135.47%
Growthannually -1,181.75%


Growthquarterly -97.48%
Growthannually -80.26%
Key to the earnings and sales forecast charts.